Depressed sarcoplasmic reticulum (SR) Ca-cycling is a hallmark of human and experimental heart failure. Strategies to improve this impairment by either increasing SERCA2a levels or decreasing phospholamban (PLN) activity have been suggested as promising therapeutic targets. Indeed, ablation of PLN gene in mice was associated with greatly enhanced cardiac Ca-cycling and performance. Intriguingly, this hyperdynamic cardiac function was maintained throughout the lifetime of the mouse without observable pathological consequences. To determine the cellular alterations in the expression or modification of myocardial proteins, which are associated with the enhanced cardiac contractility, we performed a proteomics-based analysis of PLN knockout (PLN-KO) hearts in comparison to isogenic wild-types. By use of 2-dimensional gel electrophoresis (2-DE), ~3300 distinct protein spots were detected in either wild-type or PLN-KO ventricles. Protein spots observed to be altered between PLN-KO and wild-type hearts were subjected to tryptic peptide mass fingerprinting for identification by MALDI-TOF mass spectrometry in combination with LC/MS/MS analysis. In addition, two-dimensional 32 Pautoradiography was performed to analyze the phosphorylation profiles of PLN-KO cardiomyocytes. We identified alterations in the expression level of more than 100 ventricular proteins, along with changes in phosphorylation status of important regulatory proteins in the PLN-KO. These protein changes were observed mainly in two subcellular compartments: the cardiac contractile apparatus, and metabolism/energetics. Our findings suggest that numerous alterations in protein expression and phosphorylation state occurred upon ablation of PLN and that a complex functional relationship among proteins involved in calcium handling, myofibrils, and energy production may exist to coordinately maintain the hyperdynamic cardiac contractile performance of the PLN-KO mouse in the long term. eart failure, the leading cause of disability and death, is characterized by cellular and extracellular alterations, which collectively contribute to deteriorated cardiac function and altered geometry. At the cellular levels, impaired sarcoplasmic reticulum (SR) Cacycling, partially due to depressed Ca-ATPase (SERCA2a) activity, has been observed as a universal characteristic of human and animal model heart failure. Thus, attempts to correct the depressed SR Ca-transport function have been proposed to be potentially beneficial. Indeed, animal models with increased SERCA2a expression and/or PLN ablation exhibit enhanced SR Ca-cycling and contractile performance (1-3) and may rescue the depressed cardiomyocyte Cacycling in several models of cardiac hypertrophy and/or failure (4-7). Interestingly, most of these studies have focused on the PLN-KO due to its impressive increases in cardiac SR Cacycling and function. To date, 38 research articles have been published in which the PLN-KO mouse was used as a primary investigative tool, which accounts for more than 15% of the total number of publications on PLN since the original report on the knockout mouse. Why has the PLN-KO model received so much attention? One reason is that the observed hyperdynamic cardiac function of the PLN-KO hearts is maintained throughout the lifetime of the PLN-KO mouse, and, remarkably, these mice show no signs of cardiac hypertrophy or heart failure. These hearts can sustain tremendously high basal function with no obvious detriment to their health (8). Thus, PLN was considered as a promising therapeutic target, since its inhibition/ablation seemed to improve heart function without apparent pathological consequences (9).
eart failure, the leading cause of disability and death, is characterized by cellular and extracellular alterations, which collectively contribute to deteriorated cardiac function and altered geometry. At the cellular levels, impaired sarcoplasmic reticulum (SR) Cacycling, partially due to depressed Ca-ATPase (SERCA2a) activity, has been observed as a universal characteristic of human and animal model heart failure. Thus, attempts to correct the depressed SR Ca-transport function have been proposed to be potentially beneficial. Indeed, animal models with increased SERCA2a expression and/or PLN ablation exhibit enhanced SR Ca-cycling and contractile performance (1) (2) (3) and may rescue the depressed cardiomyocyte Cacycling in several models of cardiac hypertrophy and/or failure (4) (5) (6) (7) . Interestingly, most of these studies have focused on the PLN-KO due to its impressive increases in cardiac SR Cacycling and function. To date, 38 research articles have been published in which the PLN-KO mouse was used as a primary investigative tool, which accounts for more than 15% of the total number of publications on PLN since the original report on the knockout mouse. Why has the PLN-KO model received so much attention? One reason is that the observed hyperdynamic cardiac function of the PLN-KO hearts is maintained throughout the lifetime of the PLN-KO mouse, and, remarkably, these mice show no signs of cardiac hypertrophy or heart failure. These hearts can sustain tremendously high basal function with no obvious detriment to their health (8) . Thus, PLN was considered as a promising therapeutic target, since its inhibition/ablation seemed to improve heart function without apparent pathological consequences (9) .
To date, the beneficial effects of PLN ablation in genetic mouse models of heart failure have been reported in at least 10 published studies. Overall, PLN ablation improved SR Ca 2+ cycling and myocyte contractility, but phenotypic rescue on the whole organ level varied (4-7, 10, 11) . Given the potential therapeutic value of PLN inhibition and the variable rescue of various heart failure models by PLN ablation, it becomes critical to define the full spectrum of molecular and cellular changes associated with the hyperdynamic function of PLN-deficient hearts. Our previous studies suggest that cross-talk may occur between cardiac SR and mitochondria, such that SR Ca 2+ cycling and ATP synthesis are operating in a synchronous balance, allowing the maintenance of high cardiac performance. To further identify the proteome modifications that accompany the hyperdynamic cardiac function of the PLN-KO mouse model, we integrated 2-D gel electrophoresis (2-DE), computer-assisted gel image analysis, and mass spectrometry, which together represent a powerful, high-throughput system capable of proteome-wide analysis. This approach allowed us to analyze thousands of proteins and to detect subtle and unsuspected biochemical changes in the ventricular tissues from PLN-KO mice in comparison with wildtypes. Our findings provided the basis for a comprehensive understanding of the potential players that contribute to the observed hyperdynamic cardiac function, as well as new insights into how cardiac function can be improved and maintained in the setting of physiology and pathophysiology.
MATERIALS AND METHODS

Sample preparation for two-dimensional gel electrophoresis (2-DE)
Hearts were excised from 10-12 week-old male wild-type and PLN knockout mice (SvJ129/CF1 background) (2) . After trimming connective tissue and atria, ventricular tissue was immediately frozen in liquid nitrogen and ground to a fine powder using a liquid nitrogen-cooled mortar and pestle. The powdered tissues were homogenized using a Polytron in solubilization buffer composed of 9.5 M urea, 2% CHAPS, 1% DTT, and 0.8% Pharmalyte pH 3-10. The crude extract was then centrifuged at 100,000 g at 10°C for 1 h. The supernatant was used immediately for 2-D analysis or stored at -80°C for later use. An aliquot of the supernatant was assayed for total protein concentration using the PlusOne 2D Quant Kit (Amersham Biosciences, Uppsala, Sweden).
Two-dimensional gel electrophoresis (2-DE)
First-dimensional separation was performed by using the IPGphor TM isoelectric focusing system (Amersham Biosciences). For the broad-range analysis, 150 µg of protein was diluted into rehydration buffer (8 M urea, 2% CHAPS, 20 mM DTT, 0.5% pharmalytes 3-10, and 0.01% bromophenol blue) and applied to Immobiline TM Drystrips (pH range of 3-10 NL and 4-7 NL, Amersham Biosciences). For narrow-range analysis, 250 µg of protein was diluted into rehydration buffer (8 M urea, 2% CHAPS, 20 mM DTT, 0.5% pharmalytes 3-10, and 0.01% bromophenol blue) and applied to Immobiline TM Drystrips (pH range of 4.0-5.0, 4.5-5.5, 5.0-6.0, 5.5-6.7, 6-9, Amersham Biosciences). For the basic range (pH 6-9), 200 µg of protein sample was diluted into DeStreak Rehydration Buffer (Amersham Biosciences) and applied to Immobiline™ DryStrips. All strips were rehydrated overnight at room temperature in a reswelling tray prior to being moved to ceramic strip holders and placed onto the IPGphor for isoelectric focusing. Isoelectric focusing (IEF) was performed from that point according to the manufacturer's protocols, and IEF runs were stopped at 35,000-40,000 volt-hours for the broad range pH (3-10, 4-7, and 6-9) gels and at 50,000-60,000 volt-hours for the narrow range (4.0-5.0, 4.5-5.5, 5.0-6.0, 5.5-6.7) gels. Upon completion of IEF, the IPG strips were removed from the ceramic holders and equilibrated in an SDS buffer (2% SDS; 6M urea; 30% glycerol; 50 mM Tris-HCl, pH 8.8; and 0.01% bromophenol blue) for two 15-minute intervals. The first 15-minute incubation SDS buffer contained 1% DTT, and the second contained 2.5% iodoacetamide. After equilibration, the IPG strips were placed atop 12% SDS-polyacrylamide slab gels and embedded with a 0.5% agarose solution. Gels were run in the Investigator 2D running system (Genomic Solutions, Inc., Ann Arbor, MI) containing running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS) at a regulated temperature of 15°C. The gels were run at 1500 mW until the dye front reached the bottom of the gel. Twelve cardiac ventricle samples (6 wildtype, 6 knockout) were run in triplicate per each pH range used.
The completed 2-DE gels were stained using SYPRO Ruby (Molecular Probes Inc., Eugene, OR). Briefly, each gel was fixed in 200 ml of 30% ethanol and 10% acetic acid for 1 h at room temperature on an orbital shaker platform. The fixative solution was replaced with 200 ml/gel of SYPRO Ruby staining solution. The gels were incubated overnight in staining solution, while rotating at room temperature. After staining was complete, the gels were washed twice in a solution of 10% ethanol and 5% acetic acid for 1 h. SYPRO fluorescent dye-stained gels were scanned using a FLA-3000 (Fuji Medical Systems, Stamford, CT) with a 475 nm fluorescent laser and a yellow 520 nm filter.
Two-dimensional gel image analysis
Digitized 2-D gel images were analyzed for quantitative and qualitative variations of proteins by using the Z3 ® 2-D (Compugen Inc., Jamesburg, NJ) software program and were annotated for mass spectrometry with the Melanie 3 (Swiss Bioinformatics Institute, Basel, Switzerland) software program. Replicate gels from tissue samples (3 per pH range) were matched to each other, and then against other samples from the same treatment set (wild-type or knockout) to create an averaged image, or raw master gel (RMG). The averaging of the replicate gel sets eliminates most of the gel-to-gel variation in staining intensity. The RMGs for the wild-type set (one for each pH range) and the knockout set (one for each pH range) were then matched, pairwise, against each other and analyzed to calculate the differential expression of specific protein spots. Differential expression (DE) is calculated by Z3 as a ratio; the numerator is the volume and intensity of a selected spot present in the PLN-KO RMG image, and the denominator is the volume and intensity of the corresponding spot in the wild-type RMG image. In this study, a 2-fold increase or decrease in protein expression was used as the cutoff. A DE of 2.0 or greater represents an increase in expression of 2-fold or greater, whereas a DE of 0.5 or less is equivalent to a 2-fold or greater decrease in expression in the knockout heart. Some spots in the wild-type 2D-gel image could not be matched to a corresponding spot in the KO image, and vice versa; these unmatched spots were confirmed visually and designated "exclusively detected" in KO or wild-type hearts. However, being able to detect a protein spot in only one sample may indicate either a very large difference in the protein's expression level or exclusive expression in this sample compared with its control.
In-gel digestion of proteins for mass spectrometry
Protein spots excised from Sypro Ruby stained gels were digested with trypsin according to Shevchenko and modified as described here (12) . The gel pieces were destained by using 100 µL of a 1:1 mixture of 50 mM ammonium bicarbonate:acetonitrile for 10 min, which was then dehydrated with 25 µL acetronitrile. Dehydrated gel pieces were treated with dithiothreitol (25 µL, 10 mM) and then with iodoacetic acid (25 µL, 50 mM) to reduce and alkylate the cysteine residues. Gel pieces were then twice-washed with 50 mM ammonium bicarbonate and dehydrated with 25 µL acetonitrile. The acetonitrile was removed, and the samples were then briefly dried in a vacuum centrifuge. Gel pieces were covered with 10 µL digestion buffer, containing 25 mM ammonium bicarbonate and 20 ng/µL TPCK-modified trypsin. After 45 min at room temperature, the gel pieces had re-swollen and an additional 10 uL of 50 mM ammonium bicarbonate was added. Digestion was allowed to proceed overnight at 37°C. The resulting peptides were extracted using 5% formic acid.
Protein identification via MALDI-TOF and LC-MS/MS
For MALDI-TOF identification, the tryptic peptides were loaded onto C 18 ZipTips (Millipore, Framingham, MA) for de-salting. MALDI-MS for peptide mass mapping was performed using a PerSeptive Biosystems Voyager Elite-DE (Framingham, MA) operating in reflector mode. The extracted peptide solution was mixed 1:1 with a saturated solution of a-cyano-4-hydroxycinnamic acid (in 50% acetonitrile; 0.1% TFA), and 1 µL was deposited on the sample plate and allowed to air-dry. In some cases, the peptides were also analyzed by capillary LC-MS/MS. Digest solution (10 µl) was preconcentrated and desalted on a protein trapping precolumn (CapTrap, Michrom BioResources, Aubun, CA) by using 20 µL of 1% TFA before being eluted onto a capillary column (0.3×150 mm PepMap C-18, 5 µm, 300Å; LC Packings, San Francisco, CA). An Eldex MicroPro HPLC system (Eldex Laboratories, Napa, CA) was used to deliver a step gradient at a flow rate of 5 µL/min. The column was equilibrated in 10% Buffer B (0.1% formic acid, 80% acetonitrile, 20% water) and then increased to 75% Buffer B over 35 min, followed by an increase to 95% Buffer B over 3 min and an additional 2 min. The percentage of Buffer B was then decreased to 10% for a 15-min equilibration period prior to injection of the next sample. Buffer A consisted of 0.1% formic acid, 2% acetonitrile, and 98% water. A microautosampler (Alcott 718 Al, Norcross, GA) was used for automated injections. An ion-trap mass spectrometer (LCQ, Finnigan MAT, San Jose, CA) was used for peptide sequencing. The ion trap was programmed to perform data-dependent analysis, which consisted of a first full-scan MS over the range of 300-1500 and a second scan, which was an MS/MS scan of the most abundant ion in the first scan. (13) The resulting spectra from MALDI-MS and LC-MS/MS were used to search the SWISSPROT and NCBI databases with MASCOT.
Quantitative immunoblotting
Mouse hearts were homogenized in buffer (pH 7.0) containing (mM): imidazole (10), sucrose (300), dithiothreitol (1), sodium metabisulphite (1), and phenylmethylsulfonyl fluoride (0.3). The cardiac homogenates were incubated with equal volumes of loading buffer (20% glycerol, 2% β-mercaptoethanol, 4% SDS, 0.001% bromophenol blue, and 130 mM Tris-Cl, pH 6.8), subjected to 13% SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and blotted onto nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany). The membranes were then reacted with monoclonal or polyclonal antibodies. After washing out the unbound antibody with Tris-buffered saline (10 mM Tris-HCl and 150 mM NaCl, pH 7.8), the blots were incubated with a horseradish peroxidase-conjugated secondary antibody (1:1000; Cappel Division of Organon Teknika). The specific primary antibodies to MLC1a, MLC1v, MLC2a, and MLC2v were gifts from Jeff Robbins (Children Hospital Medical Center at Cincinnati) and Kenneth Chien (University of California at San Diego). The SCAD antibody, which was raised to purified recombinant rat SCAD, was kindly provided by Jerry Vockley (Children's Hospital of Pittsburgh). It does not react with any other acyl-CoA dehydrogenases (14) . The specific antibodies to ATP synthase α-subunit, ATP synthase β-subunit (Transduction Laboratories, Newington, NH) and superoxide dismutase (US Biological, Swampscott, MA) are commercially available. The immunoreactivity was visualized by using an ECL chemiluminescence detection system (Amersham Pharmacia Biotech), and the signals were analyzed by laser densitometry using ImageQuant software.
Two-dimensional 32 P autoradiography
Left-ventricular myocytes were isolated from 3-4 month-old wild-type and PLN-KO mice following retrograde aortic perfusion of hearts with collagenase. Isolated mouse ventricular myocytes were labeled with 32 Pi, as previously described (15) . Briefly, myocytes from a single heart were suspended in 1 ml of normal Tyrode solution containing 1 mM Ca 2+ and were incubated with 0.5 mCi [
32 P]-orthophosphate for 30 min at room temperature. At the end of incubation, the 32 P-labeled cardiomyocytes were immediately pelleted, and proteins were extracted from the pellet by rapidly applying solubilization solution composed of 7 M urea, 2 M thiourea, 4% CHAPS, 20 mM DTT, 20 mM spermine, and 1 mM PMSF. The crude extract was centrifuged at 100,000 g for 1 h at 10ºC and stored at -80ºC. First-dimensional separation was performed by using the IPGphor TM isoelectric focusing system (Amersham Pharmacia Biotech, Piscataway, NJ). Protein sample (300 µg) was diluted into rehydration buffer (8 M urea, 2% CHAPS, 20 mM DTT, 0.5% IPG buffer) and applied to nonlinear Immobiline TM Drystrips (Amersham Pharmacia Biotech). IEF and second-dimension electrophoresis were performed as described above. Following SDS-PAGE, gels were fixed briefly in 30% ethanol/10% acetic acid and then placed directly onto phosphoimage screens for exposure. Following overnight exposures, the phosphoimage screens were analyzed using Storm PhosphorImager (Molecular Dynamics). Images of 32 P from the phosphoimager and images of silver-stained gels were converted to TIFF files and imported into ImageMaster 2D Elite software (Amersham Pharmacia Biotech) for analysis. Functions performed by the software included spot detection, spot matching, and calculation of spot intensity volumes (the sum of intensity values of pixels in the area outlined for the spot, normalized to the total staining intensity volume of the gel). Normalization compensated for any differences in protein loading or staining. To align autoradiograms and silver-stained images, both silver-stained and autoradiography images were acquired from the same 2D gel and imported into the 2D Elite ImageMaster software for spot detection and matching. This was done to allow for comparison of spots found in the silverstained image with the autoradiographic image, and for subsequent mass spectrometric identification, as previously described. (15) 
RESULTS
Protein expression profile upon PLN ablation
To maximally determine the cellular alterations associated with the hyperdynamic PLN-KO hearts, we used an unbiased proteomic approach. Ventricular proteins from wild-type and PLN-KO mice were solubilized, processed in parallel, and loaded onto pH 3-10 and 4-7 immobilized pH gradient (IPG) strips. Vertical second-dimension SDS-PAGE (12% gels) was performed immediately following IEF. Using this method, image analysis software detected approximately 1100 spots on each SYPRO stained broad-range gel. Internal analysis of the knockout and wildtype gel images demonstrated a 99% reproducibility between gels. 2D-gel images of wild-type and PLN knockout ventricular tissues were analyzed for the purposes of quantitative spot comparisons using Z3 ® Image Analysis software (Compugen Inc.). Raw Master Gel (RMG) images were first generated for the wild-type (Fig. 1A) and PLN-KO (Fig. 1B) protein profiles by averaging three individual gel images for each pH range; these images could display the differences in protein spot intensity and size (Fig. 1A-D) . The differential expression (DE) was calculated for every spot that could be matched between the two RMGs by Z3 ® . Comparison of the RMGs showed that ablation of PLN was associated with a 2-fold increase in the expression of 34 protein spots and a 2-fold decrease in the expression of 26 proteins. Furthermore, 83 proteins were detected "exclusively" in the wild-type protein profile, whereas 51 proteins were detected "exclusively" in the knockout profile under the conditions used.
Wild-type and PLN-KO cardiac homogenates were also run on narrow pH range 18 cm IPG strips (pH ranges: 6-9, 4.0-5.0, 4.5-5.5, 5.0-6.0, and 5.5-6.7). Because of their more specific pH range, the narrow-range gel strips allowed for better protein spot resolution than broad-range (pH 3-10) strips, which results in an increase in the number of detectable spots. Samples were isoelectrically focused on the narrow-range strips and then immediately run on vertical SDS-PAGE (12%) gels, as described for broad-range gels. Analysis of the images demonstrated that ~1300 spots could be detected in each narrow range gel; after overlaying the gel images from various pH ranges and subtracting common protein spots between overlapping pH ranges, ~3300 distinct spots could be resolved between pH 4-7. Thus, running five narrow pH range strips and summing the results allowed us to observe a 3-fold increase in the number of detectable protein spots compared with a single pH 4-7 or 3-10NL IPG 18 cm strip. The resulting composite overlay image of narrow range gels between pH 4.0 to 6.7 is shown in Fig. 2 . The use of DeStreak rehydration solution dramatically increased the resolution of basic proteins (pH 6-9) by reducing horizontal streaking (data not shown). Pairwise analysis of the narrow range RMG images was performed by Z3 ® , and the DE was calculated for each matched spot. From pairwise analysis, 49 proteins were found to be significantly up-regulated and 26 proteins were found to be down-regulated, among which 18 proteins were detectable exclusively in the PLN-KO and 8 were detectable exclusively in the wild-type hearts.
Protein identification by MALDI-TOF and LC-MS/MS
Protein spots with significant differences (>2-fold) in abundance between wild-type and PLN knockout homogenates in both broad and narrow pH-range strip conditions were excised, washed, treated with trypsin, eluted, and subjected to MALDI-MS or LC-MS/MS for identification. In total, 666 spots were excised from gels and processed for identification. Proteins were identified via database searches, using peptide masses; the parameters for database searching included enzyme specificity, mass accuracy, error tolerance, and limits on the molecular weight of the intact protein under study. Allowances were made for partial digestion, cysteine modifications, and oxidation of methionine. Trypsin autolysis peaks and common keratin contaminants were excluded. The proteins successfully identified are listed in Table 1 . Mass mapping of the in-gel digests of protein spots by using MALDI-TOF and/or LC-MS/MS mass spectrometry techniques were obtained for protein database searches. The overall protein identification rate was 18%, i.e., 68 out of 435 proteins were identified by MALDI-TOF, while 54 out of 231 proteins were identified by LC-MS/MS. Though a total of 122 proteins were identified through analysis of mass spectrometry data from MALDI-TOF and LC-MS/MS, multiple isoforms of proteins as well as overlapping identifications of protein species between the two mass spectrometry methods decreased the number of unique protein identifications to the 34 listed in Table 1 .
Confirmation of differential protein expression in PLN-KO hearts
To confirm the findings revealed by 2-D gel analysis and mass spectrometry, quantitative Western blotting on selected proteins (Fig. 3) was used. Two of the identified protein spots corresponded to the two subunits of the myosin light chain (MLC-1 and MLC-2; Fig. 3A ), which associate with the heavy chains to form a functional contractile unit. 2-D gel analysis suggested that: 1) the atrial isoform of MLC-1 (MLC-1a) was down-regulated (21 ± 6%); and 2) the ventricular isoform of MLC-1 (MLC-1v) was up-regulated (16 ± 4%). Western blotting confirmed these observations for myosin light chains (Fig. 3B) . In addition, MLC-2a levels were increased (39 ± 6%), and MLC-2v levels remained unchanged in the PLN knockout mouse ventricles, compared with wild-types (Fig. 3B) . Quantitative Western blots were also performed for ATP-synthase α subunit (down 22 ± 4%) and superoxide dismutase (up 41 ± 6%), which confirmed the observations revealed by 2-D image analysis (Fig. 3B) . However, Western blotting analysis did not reveal significant alteration of ATP-synthase β subunit, not reflective of changes observed in the 2D gels.
Post-translational modifications in PLN-KO hearts
Several changes in the post-translational protein modification state upon PLN ablation were identified using a combination of 2-DE, radiography, and mass spectrometry. Post-translational modification must be differentiated from altered protein expression on 2-D gels. One such example is exemplified in Fig. 4A , where the different spot patterns may represent a shift in the pI of a single protein or may be due to up-regulation of one protein and down-regulation of a second protein. Using a combination of methods, we determined that the difference in protein patterns, observed in Fig. 4A , resulted from a change in the expression level and isoelectric point of the short-chain acyl-CoA dehydrogenase (SCAD) upon PLN ablation. First, mass spectrometry identified both spots in Fig. 4A as SCAD (Fig. 4B) . To further confirm the identity of these spots, 2-D gels were transferred to nitrocellulose membranes and probed with an antibody against human SCAD. 2-D Western blot analysis identified that part of the SCAD migrated at a more acidic pI in the KO tissue, whereas its molecular weight remained unchanged, consistent with the findings from image analysis of stained 2-D gels (Fig. 4C) . Finally, quantitative immunoblotting of 1D gels with a polyclonal antibody to SCAD demonstrated that it was up-regulated by ~2-fold in PLN-KO ventricles (11.7 ± 0.8 in KO vs. 5.2 ± 0.5 in WT, P<0.001, n=8; Fig. 4D ). Because no isoform of SCAD has been identified to date, the pI shift suggested a post-translational modification of the enzyme.
Of particular importance in cardiac physiology is the phosphorylation state of both myofilament and energy-production proteins, since phosphorylation tightly regulates overall cardiac output and contractility. To determine whether increased or decreased phosphorylation of myocyte proteins was associated with ablation of PLN, isolated cardiomyocytes were labeled with 32 P i , processed for 2-D gel electrophoresis and subjected to autoradiography (Fig. 5) . Image analysis of the autoradiograms revealed a significant difference in phosphorylation of five protein spots; identification of these proteins has been described previously (15) . Phosphorylation of succinate CoA synthetase was decreased, whereas the phosphorylation of MLC-2, pyruvate dehydrogenase, heat-shock protein-27, and αB-crystallin were increased (Fig. 6 ). Notably, the phosphorylation level of cardiac TnI was not altered between the two groups, consistent with the previous report (16) .
DISCUSSION
For the past decade, the PLN-KO mouse model has provided a great deal of insights into cardiac SR function and its role in regulating cardiac contractility. The wealth of information gained from studies in this model contrasts with our lack of understanding of the subcellular players maintaining the heightened basal cardiac performance over the long term without apparent negative pathophysiologic consequences. A combination of 2-D gel electrophoresis, mass spectrometry, and autoradiography was used in this study in an attempt to map changes in ventricular protein expression of the hyperdynamic PLN deficient hearts. These studies indicate that ablation of PLN is associated with a large number of previously unrecognized alterations in myocardial protein expression patterns, which may contribute to or compensate for the cardiac phenotype of the hyperdynamic function. Interestingly, the major protein alterations, associated with PLN ablation, can be grouped into two major categories: energy production proteins and contractile proteins.
Energy producing proteins
The hyperdynamic state of the PLN-KO heart places a large demand on the myocyte energy production system. Accordingly, our results suggest that the enzymes responsible for β-oxidation of fatty acids, along with Krebs cycle enzymes, are increased in the KO ventricles. This suggests that cross-talk must exist between mitochondria and SR to maintain a balance between energy production and consumption. A schematic representation of the identified changes in energy production proteins is summarized in Fig. 7 .
Evidence for an increase in fatty acid β-oxidation in PLN-KO hearts comes from changes in the level of several enzymes. First, both medium-chain acyl-CoA dehydrogenase and short-chain acyl-CoA dehydrogenase (MCAD and SCAD) were significantly increased upon PLN ablation. Acyl-CoA dehydrogenases catalyze the first step of mitochondrial fatty acid β-oxidation; SCAD breaks down fatty acids less than 6 carbons long into acetyl-CoA, while MCAD breaks down fatty acids between 12 and 6 carbons long. In parallel, electron transfer flavoprotein alpha and electron transfer flavoprotein beta were also up-regulated; these two proteins act as electron acceptors from dehydrogenases such as MCAD and SCAD. In addition to an increased expression level, a significant shift to a lower pI value of SCAD was observed, indicating posttranslational addition of an acidic moiety, possibly a phosphate group, in the PLB-KO hearts. Software programs predict the presence of nine possible serine phosphorylation sites, eight possible threonine phosphorylation sites, and three possible tyrosine phosphorylation sites (NetPhos 2.0 Server). Unfortunately, multiple trials of LC-MS/MS phosphorylation mapping analysis were inconclusive in determining whether this was in fact phosphorylation. Though the exact identity and significance of this post-translational modification are still unknown, this modification may represent a metabolic adaptation made to facilitate a higher rate of fatty acid metabolism in the hearts of the PLN knockout mice.
To handle the increased load of Acetyl-CoA that would result from increased β-oxidation, several enzymes of the Krebs cycle were also up-regulated, including succinyl-CoA ligase, fumarase, and malate dehydrogenase (Fig. 7) . Similarly, we observed a decrease in the phosphorylation of succinyl-CoA synthetase. The up-regulation of these enzymes would facilitate the transfer of high-energy electrons to NAD and FADH for use in ATP synthesis. Thus, from the beginning of the pathway to the end, enzymes involved in β-oxidation are upregulated to produce energy more rapidly in the PLN-KO ventricle.
In parallel with the increases in β-oxidation was a decrease in the expression of several enzymes of the glycolysis pathway. Fructose-bisphosphate aldolase A, β-enolase, and pyruvate dehydrogenase E1 were each down-regulated, along with a two-fold increase in the phosphorylation level of pyruvate dehydrogenase. Phosphorylation of pyruvate dehydrogenase decreases this enzyme's activity. Because cardiac myocytes derive ~65% of their energy from fatty acid metabolism and ~30% from glucose metabolism, our results suggest that the PLN-KO myocytes strive to generate an even greater majority of their energy from fatty acid metabolism and derive less energy from the slower, lower-yield glycolytic pathway.
Finally, such high levels of aerobic respiration would likely produce higher levels of oxygen free radical species in PLN-KO myocytes. We have observed an increase in peroxiredoxin, antioxidant protein 2, and superoxide dismutase, all of which help maintain the reduction state of the cell and scavenge free radicals. The up-regulation of these proteins would help protect cellular components from oxidative damage by free radical species.
Contractile proteins
The atrial isoform of MLC-1 (MLC-1a) was down-regulated, whereas the ventricular isoform of MLC-1 (MLC-1v) was up-regulated in PLN-KO ventricles. Interestingly, ventricular expression of MLC-1a, which is normally suppressed after birth, was reported to accompany cardiac hypertrophy (17) . MLC-2a, which has been associated with dilated cardiomyopathy in humans, was also identified in the present study; its expression was increased, as evidenced by 2-D gel analysis and quantitative immunoblotting. Additionally, 2D
32 P autoradiography revealed a significant increase in phosphorylation level of MLC-2v in PLN-KO ventricle compared with wild-type. Phosphorylation of MLC-2v accompanies sarcomere organization and may facilitate the incorporation of additional actin/myosin filaments into the sarcomere, allowing for higher organization of the sarcomeric architecture. (18) Furthermore, phosphorylation of MLC-2v increases the calcium sensitivity of the myofilaments, thereby increasing contractility. (19) In contrast, a transgenic mouse with overexpression of a MLC-2v form that cannot undergo phosphorylation, exhibited decreased calcium sensitivity and cardiomyopathy. (20) These findings indicate that ablation of PLN is associated with MLC-1 isoform switching and increased MLC-2v phosphorylation, both of which would contribute to the hyperdynamic contractile properties in the PLN-KO hearts.
The expression of two other contractile proteins, Tropomyosin-1 and Troponin T, were found to be altered upon PLN ablation. Troponin T (TnT) is the tropomyosin-binding component of troponin, and it is through TnT that Troponins C and I exert their regulation of myosin-actin interactions. (21) Mutations in TnT are known to be a primary cause of hypertrophic cardiomyopathy. (22, 23) Furthermore, Javadpour et al have recently reported an intriguing link between TnT and energy usage (24) . Transgenic mice possessing a troponin T mutation (R92Q) demonstrate a decrease in free energy released by ATP hydrolysis, which resulted in an inability to support contractile work and in a marked inability to increase contractile performance upon acute inotropic challenge. It was suggested that the structural changes associated with the R92Q missense mutation in the tropomyosin-binding domain of TnT may lead to less efficient ATP utilization. Our findings reinforce the notion that Troponin T is involved in the regulation of myocyte energetics, and its lower expression in PLN-KO mice may be reflective of myofilament compensation in response to heightened cellular energy utilization.
The tropomyosins, which include Tropomyosin α, β, 1, 2, and 3, dynamically regulate the architecture of myofilaments by binding actin filaments and Troponin T, and are involved in regulating the interaction between actin and myosin. (25) With regard to tropomyosin-1, several reports indicate that a tumor-suppressor protein is involved in the regulation of anchoragedependent cellular growth. (26, 27 ) Down-regulation of tropomyosin 1 is associated with cellular transformation in cell culture (28) ; furthermore, Tropomyosin-1 is phosphorylated by ERK in endothelial cells, which causes association of Tropomyosin-1 with actin bundles. (29) In cardiac myocytes, ERK is a known promoter of hypertrophy (30) , but no evidence indicates that ERK phosphorylates Tropomyosin 1 in cardiac cells. In light of these facts, we speculate a link between Tropomyosin 1 up-regulation and the lack of hypertrophy in the hyperdynamic PLN-KO myocytes through the aging process. However, it should also be noted that the proteins that are up-regulated may not be incorporated into the myofilaments. In addition, a previous report (31) indicated that PLN knockout hearts do not show any alteration in Ca-activated force as well as the myosin ATPase activity compared with wild type hearts.
Finally, we observed a 1.5-and 2.0-fold increase in the phosphorylation of heat-shock protein 27 and αB-crystallin, respectively. Reports indicate that when these two homologous chaperone proteins are phosphorylated, oligomers of each protein dissociate and exert strong anti-apoptotic effects in the nucleus and mitochondria. (32, 33) Thus, the increased phosphorylation of the two chaperone proteins may ameliorate the chronic stress of maintaining enhanced basal contractile performance and prevent apoptosis in the PLN-KO hearts.
Limitations
2-DE as yet faces a few limitations regarding the type of proteins it can resolve and detect. The conditions used for sample preparation in 2-DE favor the detection of relatively abundant cytosolic proteins; conditions have yet to be developed that can adequately solubilize highly hydrophobic proteins. Furthermore, broad-range 2-DE gel electrophoresis on its own fails to detect low-abundance proteins. This can be overcome through the use of narrow-range IPG strips, which facilitate the detection of these low-abundance proteins by creating a larger frame of resolution for protein separation. Another limitation in proteomic analysis is that 2-D gels are still unable to easily separate proteins possessing extremely acidic (<4) or basic (>8) isoelectric points, nor can they adequately display proteins at the two extremes of molecular weight. Thus, altered expression patterns of: 1) low-abundance proteins such as growth factors; 2) hydrophobic proteins such as receptors; and 3) highly acidic or basic proteins, such as calciumbinding proteins or DNA-binding proteins almost certainly exist, but could not be detected herein due to technical limitations. However, in a recent report by Pan et al (34) , the authors successfully used high-throughput gel-free tandem MS and performed proteomic analysis of membrane proteins in microsomal fractions isolated from the PLN-deficient mice and transgenic mice expressing a superinhibitory PLN mutant. Significant differential expression was observed in a subset of the 782 proteins identified. The advantage of such an approach is the ability to investigate the membrane proteins, a limitation of gel-based systems.
The sensitivity of mass spectrometery also limits the identification of low-abundance and basic proteins. In the present study, 80% of proteins could not be identified by mass spectrometry, limiting the scope of our investigation. Some increase in sensitivity of mass spectrometric techniques can be gained by the use of ZipTips ® and increased protein loads per gel, but limitations still exist due to equipment sensitivity.
Conclusions
The ablation of a single SR membrane phosphoprotein PLN is associated with alterations in protein expression levels of several hundred proteins localized in multiple subcellular compartments. In sum, this study has uncovered two major differences in the PLN-KO cardiac proteome: 1) fatty acid β-oxidation is up-regulated in an effort to meet the energetic demands of enhanced SR calcium cycling and hyperdynamic function; and 2) myofilament alterations occur that may result in higher sarcomeric organization and efficient ATP utilization, which could potentially be anti-hypertrophic and anti-apoptotic in nature. These findings suggest that following PLN ablation, cross-talk or synergism occurs among SR Ca 2+ cycling proteins, the contractile apparatus, and the mitochondrial ATP production machinery to maintain the "physiological" hyperdynamic steady state of contractility in PLN-KO hearts. Approximately 3300 distinct protein spots can be visualized by using narrow-range zoom gel technique (single counting of overlapping areas), as opposed to only ~1000 spots on pH 3-10 IEF strips. The 2-D gels were stained with SYPRO Ruby. Spots appearing as green were down-regulated or observed in wild-type tissue only, while spots appearing as pink were upregulated or observed only in tissue upon ablation of PLN. Green spots: wild-type. Pink spots: knockout. Black spots: spots that are matched between wild-type and knockout hearts.
Fig. 3
Page 22 of 30 (page number not for citation purposes) Fig. 3 (cont)   Figure 3 . A) Two-dimensional resolution of myosin light chain isoforms. On the left, the wild-type expression pattern of MLC1a, MLC1v, and MLC2 are shown. On the right, the comparative PLN knockout expression pattern is shown. MLC1a expression decreased in KO tissue, whereas MLC1v expression increased. No significant change was detected in the level of MLC2v. B) Confirmation of protein expression alterations observed in PLN-KO ventricles. Quantitative Western blots were performed for ATP synthase subunits α and β, superoxide dismutase, MLC-1a, MLC2a, MLC2a, and MLC2v. Cardiac proteins from wild-type and PLN-KO ventricles were subjected to 12% SDS-PAGE, transferred to nitrocellulose and reacted with the appropriate specific primary antibodies (see Materials and Methods). Protein loadings and linear range are indicated. Fig. 4 (cont)   Figure 4 . A) Up-regulation and pI shift of SCAD in PLN-KO hearts. Comparison of the two images shows a shift to the left of a single protein spot. This spot was subsequently determined to be SCAD (short-chain acyl-CoA dehydrogenase) in both gels by Western blotting and mass spectrometry, reflective of a shift in pI due to post-translational modification. B) Identification of SCAD by MALDI-MS. The two spots shown in Fig. 4A were excised and identified as SCAD (using tryptic peptide mass fingerprinting). This suggests post-translational modification of this protein in the PLN-knockout mouse. Peaks that match with SCAD are indicated numerically. T: trypsin fragment. C) Two-dimensional Western immunoblot of SCAD. 2-D electrophoresis of mouse ventricular proteins (150 µg) and immunoblotting were performed by using a polyclonal anti-human SCAD. The isoelectric point (pI) of SCAD was shifted to a lower value upon PLB ablation. D) Quantitative immunoblot confirming up-regulation of SCAD in PLB-KO ventricles. Cardiac (10 µg) proteins from wild-type and PLN knockout ventricles were subjected to 13% SDS-PAGE and immunoblotted by using a polyclonal antibody against rat SCAD (1/1000). Protein loadings and linear range are indicated in the figure. Values are mean ± SE. *P < 0.001, n = 8. 32 P-labeled gel images were quantified by ImageMaster 2D Elite software, and spots that changed in size or intensity were then identified in corresponding silver-stained gels. These spots were destained, digested, and subjected to MALDI-TOF spectrometric identification. The phosphorylation state of six proteins were identified by this method: myosin light chain-2 (MLC-2), troponin I (TnI), pyruvate dehydrogenase (PDH), succinyl-CoA synthetase (SCS), heat-shock protein-27 (HSP-27), and αB-crystallin (αBC). Values = mean ± SEM, n = 6-8; *P < 0.05. 
